Aberrant Expression of Epithelial-Mesenchymal Transition Markers in Early Gastric Cancer: Clinical Application

참고문헌 (9)

1. Herrero R, "The fight against gastric cancer-the IARC Working Group report", Best Pract Res Clin Gastroenterol, 28, pp.1107~1114 (2014)
2. Gotoda T, "Incidence of lymph node metastasis from early gastric cancer : estimation with a large number of cases at two large centers", Gastric Cancer, 3, pp.219~225 (2000)
3. Ono H, "Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer", Dig Endosc, 28, pp.3~15 (2016)
4. 방창석, "Therapeutic Outcomes of Endoscopic Resection of Early Gastric Cancer with Undifferentiated-Type Histology: A Korean ESD Registry Database Analysis", Clinical Endoscopy, 50(6), pp.569~577 (2017), 대한소화기내시경학회
5. Peng Z, "Role of epithelial-mesenchymal transition in gastric cancer initiation and progression", World J Gastroenterol, 20, pp.5403~5410 (2014)
6. Cho SY, "Sporadic early-onset diffuse gastric cancers have high frequency of somatic CDH1 alterations, but low frequency of somatic RHOA mutations compared with late-onset cancers", Gastroenterology, 153, pp.536~549 (2017)
7. Hee Jae Jung, "Immunohistochemical Expression of Epithelial-Mesenchymal Transition Markers in Early Gastric Cancer: Cancer Tissue versus Noncancer Tissue", Clinical Endoscopy, 52(5), pp.464~471 (2019), 대한소화기내시경학회[DOI]
8. Chen HC, "Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas", Cancer Lett, 201, pp.97~106 (2003)
9. Kim SH, "Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells", BMC Cancer, 18, pp.150~ (2018)

관련 논문AI추천